Interestingly, we found only RUNX2 had significant reduction compared with normal controls in saliva and blood cells (GSE14245 and GSE49641), which suggested that RUNX2 could be considered as one of promising candidate biomarkers of PC. Here, RUNX2 is linked to pachyonychia congenita.